Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Towards anticancer fluoroquinolones: A review article
Mohamed A. A. Abdel‐Aal, Salah A. Abdel‐Aziz, Montaser Sh. A. Shaykoon, et al.
Archiv der Pharmazie (2019) Vol. 352, Iss. 7
Closed Access | Times Cited: 54

Showing 1-25 of 54 citing articles:

Chemical Aspects of Human and Environmental Overload with Fluorine
Jianlin Han, Lóránd Kiss, Haibo Mei, et al.
Chemical Reviews (2021) Vol. 121, Iss. 8, pp. 4678-4742
Open Access | Times Cited: 333
Ferrocene-containing hybrids as potential anticancer agents: Current developments, mechanisms of action and structure-activity relationships
Ruo Wang, Huahong Chen, Weitao Yan, et al.
European Journal of Medicinal Chemistry (2020) Vol. 190, pp. 112109-112109
Closed Access | Times Cited: 165
Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy
Osama M. Soltan, Mai E. Shoman, Salah A. Abdel‐Aziz, et al.
European Journal of Medicinal Chemistry (2021) Vol. 225, pp. 113768-113768
Closed Access | Times Cited: 87
New 1,2,3-triazole linked ciprofloxacin-chalcones induce DNA damage by inhibiting human topoisomerase I& II and tubulin polymerization
Hamada H. H. Mohammed, Amer Ali Abd El‐Hafeez, Kareem Ebeid, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1346-1363
Open Access | Times Cited: 39
Topoisomerase II inhibitors design: Early studies and new perspectives
Hadeer K. Swedan, Asmaa E. Kassab, Ehab M. Gedawy, et al.
Bioorganic Chemistry (2023) Vol. 136, pp. 106548-106548
Closed Access | Times Cited: 26
New series of fluoroquinolone derivatives as potential anticancer Agents: Design, Synthesis, in vitro biological Evaluation, and Topoisomerase II Inhibition
Mina E. Adly, Azza T. Taher, Fakher M. Ahmed, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108163-108163
Closed Access | Times Cited: 1
Recent Development of Fluoroquinolone Derivatives as Anticancer Agents
Justyna Nowakowska, Dominika Radomska, Robert Czarnomysy, et al.
Molecules (2024) Vol. 29, Iss. 15, pp. 3538-3538
Open Access | Times Cited: 7
Design and synthesis of novel cytotoxic fluoroquinolone analogs through topoisomerase inhibition, cell cycle arrest, and apoptosis
Mohamed A. Elanany, Essam Eldin A. Osman, Ehab M. Gedawy, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Engineered extracellular vesicles coated with an antimicrobial peptide for advanced control of bacterial sepsis
Usri H. Ibrahim, Mohammed A. Gafar, René B. Khan, et al.
Journal of Extracellular Biology (2024) Vol. 3, Iss. 8
Open Access | Times Cited: 5
Insights on fluoroquinolones in cancer therapy: chemistry and recent developments
Prabodh Chander Sharma, Rajat Goyal, Archana Sharma, et al.
Materials Today Chemistry (2020) Vol. 17, pp. 100296-100296
Closed Access | Times Cited: 37
Novel and Structurally Diversified Bacterial DNA Gyrase Inhibitors Discovered through a Fluorescence-Based High-Throughput Screening Assay
Eddy E. Alfonso, Zifang Deng, Daniel Boaretto, et al.
ACS Pharmacology & Translational Science (2022) Vol. 5, Iss. 10, pp. 932-944
Open Access | Times Cited: 21
Design, synthesis, and biological evaluation of novel ciprofloxacin derivatives as potential anticancer agents targeting topoisomerase II enzyme
Hadeer K. Swedan, Asmaa E. Kassab, Ehab M. Gedawy, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 38, Iss. 1, pp. 118-137
Open Access | Times Cited: 21
The New Face of a Well-Known Antibiotic: A Review of the Anticancer Activity of Enoxacin and Its Derivatives
Karolina Jałbrzykowska, Alicja Chrzanowska, Piotr Roszkowski, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3056-3056
Open Access | Times Cited: 20
Dual Topoisomerase I/II Inhibition-Induced Apoptosis and Necro-Apoptosis in Cancer Cells by a Novel Ciprofloxacin Derivative via RIPK1/RIPK3/MLKL Activation
Rania Alaaeldin, Islam M. Abdel-Rahman, Fares E.M. Ali, et al.
Molecules (2022) Vol. 27, Iss. 22, pp. 7993-7993
Open Access | Times Cited: 20
A Comprehensive Review on Chemical Synthesis and Chemotherapeutic Potential of 3-Heteroaryl Fluoroquinolone Hybrids
Halyna Hryhoriv, Sergiy М. Kovalenko, Marine Georgiyants, et al.
Antibiotics (2023) Vol. 12, Iss. 3, pp. 625-625
Open Access | Times Cited: 12
Current updates on green synthesis and biological properties of 4-quinolone derivatives
Shivangi Jaiswal, Nikhilesh Arya, Neetu Yaduvanshi, et al.
Journal of Molecular Structure (2023) Vol. 1294, pp. 136565-136565
Closed Access | Times Cited: 11
Mechanisms of the Antineoplastic Effects of New Fluoroquinolones in 2D and 3D Human Breast and Bladder Cancer Cell Lines
N. Ferrario, Emanuela Marras, Veronica Vivona, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2227-2227
Open Access | Times Cited: 4
Quinolin-4-ones: Methods of Synthesis and Application in Medicine
Katarzyna Gach, Justyna Piekielna‐Ciesielska, J. L. Waskiewicz, et al.
Molecules (2025) Vol. 30, Iss. 1, pp. 163-163
Open Access
Nitric Oxide Photo-Donor Hybrids of Ciprofloxacin and Norfloxacin: A Shift in Activity from Antimicrobial to Anticancer Agents
Antonino N. Fallica, Carla Barbaraci, Emanuele Amata, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 15, pp. 11597-11613
Open Access | Times Cited: 24
From Infection to Tumor: Exploring the Therapeutic Potential of Ciprofloxacin Derivatives as Anticancer Agents
Hesham M. Hassan, Roket Hassan, Ranya Mohammed Elmagzoub, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 72-72
Open Access
Modulating microRNA Processing: Enoxacin, the Progenitor of a New Class of Drugs
Tommaso Felicetti, Violetta Cecchetti, Giuseppe Manfroni
Journal of Medicinal Chemistry (2020) Vol. 63, Iss. 21, pp. 12275-12289
Open Access | Times Cited: 27
Novel urea linked ciprofloxacin-chalcone hybrids having antiproliferative topoisomerases I/II inhibitory activities and caspases-mediated apoptosis
Hamada H. H. Mohammed, Samar H. Abbas, Alaa M. Hayallah, et al.
Bioorganic Chemistry (2020) Vol. 106, pp. 104422-104422
Closed Access | Times Cited: 26
In silico drug repurposing in COVID-19: A network-based analysis
Pasquale Sibilio, Simone Bini, Giulia Fiscon, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 142, pp. 111954-111954
Open Access | Times Cited: 20
Synthesis and anticancer activity of ethyl 5‐amino‐1‐N‐substituted‐imidazole‐4‐carboxylate building blocks
Zukela Ruzi, Lifei Nie, Khurshed Bozorov, et al.
Archiv der Pharmazie (2021) Vol. 354, Iss. 9
Closed Access | Times Cited: 19
Ciprofloxacin and Norfloxacin Hybrid Compounds: Potential Anticancer Agents
Sijongesonke Peter, Blessing A. Aderibigbe
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 7, pp. 644-665
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top